Playback speed
10 seconds
Rituximab, Lenalidomide, and Ibrutinib Prior to Chemo in Newly Diagnosed DLBCL & Impact of Eligibility Criteria on Outcomes
931 views
March 4, 2020
Login to view comments.
Click here to Login